KPTI Statistiques clés
Haut
7.16
Ouverture
7.14
Volume
147.89K
Bas
6.88
Clôture précédente
7.18
Valeur négociée
1.03M
Plus haut 52 sem.
10.99
Vol. relatif
0.227
Amplitude (%)
3.83%
Plus bas 52 sem.
3.65
Taux de rotation
0.65%
Cap. Marché
162.71M
PER (TTM)
--
PER (Annuel)
--
P/B
-0.61
P/S
1.08
Bénéfice par action (BPA)
-15.087
Dividende (TTM)
0
Rendement du dividende
0.00%
Actions en circulation
22.66M
Devise
USD
KPTI Performance du Prix
7 jour
30 jour
90 jour
180 jour
Depuis le début de l’année
1 An
KPTI Répartition des flux monétaires
KPTI Volume quotidien des ventes à découvert
KPTI Historique du short interest
KPTI Aperçu de l’action
As of 2026-07-23, the Karyopharm Therapeutics Inc. (KPTI) stock price today is 6.98. Based on this price, the company has a market capitalization of $162.71M, with a P/E ratio of --.
On 2026-07-23, KPTI traded between 6.88 and 7.16. Today’s stock price is 1.45% above the daily low and 2.51% below the daily high, placing KPTI dans la partie basse de its most recent trading range.
Trading volume currently stands at 147.89K, compared with an average daily volume of 652.77K. This suggests that trading activity is nettement inférieur à son niveau habituel than usual.
Over the past year, Karyopharm Therapeutics Inc. shares have traded between 3.65 and 10.99. At today’s price, KPTI is 91.23% above its 52-week low and 36.49% below its 52-week high.
KPTI Actualités liées
À propos KPTI
Nom l'entreprise
Karyopharm Therapeutics Inc.
Secteur
Health Technology
Industrie
Pharmaceuticals: Major
Exchanges
Nasdaq
Nombre d’employés
228
Taille du lot
100
Site officiel
Devise
USD
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
Related Stocks
KPTI FAQ
© 2026 CoinGlass, all rights reserved
